165 related articles for article (PubMed ID: 26460502)
1. Inhibition of APOBEC3G activity impedes double-stranded DNA repair.
Prabhu P; Shandilya SM; Britan-Rosich E; Nagler A; Schiffer CA; Kotler M
FEBS J; 2016 Jan; 283(1):112-29. PubMed ID: 26460502
[TBL] [Abstract][Full Text] [Related]
2. Multifaceted counter-APOBEC3G mechanisms employed by HIV-1 Vif.
Britan-Rosich E; Nowarski R; Kotler M
J Mol Biol; 2011 Jul; 410(5):1065-76. PubMed ID: 21763507
[TBL] [Abstract][Full Text] [Related]
3. Characterization of conserved motifs in HIV-1 Vif required for APOBEC3G and APOBEC3F interaction.
He Z; Zhang W; Chen G; Xu R; Yu XF
J Mol Biol; 2008 Sep; 381(4):1000-11. PubMed ID: 18619467
[TBL] [Abstract][Full Text] [Related]
4. APOBEC3G enhances lymphoma cell radioresistance by promoting cytidine deaminase-dependent DNA repair.
Nowarski R; Wilner OI; Cheshin O; Shahar OD; Kenig E; Baraz L; Britan-Rosich E; Nagler A; Harris RS; Goldberg M; Willner I; Kotler M
Blood; 2012 Jul; 120(2):366-75. PubMed ID: 22645179
[TBL] [Abstract][Full Text] [Related]
5. Reassessing APOBEC3G Inhibition by HIV-1 Vif-Derived Peptides.
Richards CM; Li M; Perkins AL; Rathore A; Harki DA; Harris RS
J Mol Biol; 2017 Jan; 429(1):88-96. PubMed ID: 27887868
[TBL] [Abstract][Full Text] [Related]
6. Dimerization regulates both deaminase-dependent and deaminase-independent HIV-1 restriction by APOBEC3G.
Morse M; Huo R; Feng Y; Rouzina I; Chelico L; Williams MC
Nat Commun; 2017 Sep; 8(1):597. PubMed ID: 28928403
[TBL] [Abstract][Full Text] [Related]
7. Quantitative analysis of location- and sequence-dependent deamination by APOBEC3G using real-time NMR spectroscopy.
Furukawa A; Sugase K; Morishita R; Nagata T; Kodaki T; Takaori-Kondo A; Ryo A; Katahira M
Angew Chem Int Ed Engl; 2014 Feb; 53(9):2349-52. PubMed ID: 24478136
[TBL] [Abstract][Full Text] [Related]
8. APOBEC3G inhibits HIV-1 RNA elongation by inactivating the viral trans-activation response element.
Nowarski R; Prabhu P; Kenig E; Smith Y; Britan-Rosich E; Kotler M
J Mol Biol; 2014 Jul; 426(15):2840-53. PubMed ID: 24859335
[TBL] [Abstract][Full Text] [Related]
9. Identification of two distinct human immunodeficiency virus type 1 Vif determinants critical for interactions with human APOBEC3G and APOBEC3F.
Russell RA; Pathak VK
J Virol; 2007 Aug; 81(15):8201-10. PubMed ID: 17522216
[TBL] [Abstract][Full Text] [Related]
10. T cells contain an RNase-insensitive inhibitor of APOBEC3G deaminase activity.
Thielen BK; Klein KC; Walker LW; Rieck M; Buckner JH; Tomblingson GW; Lingappa JR
PLoS Pathog; 2007 Sep; 3(9):1320-34. PubMed ID: 17892323
[TBL] [Abstract][Full Text] [Related]
11. RNA-binding residues in the N-terminus of APOBEC3G influence its DNA sequence specificity and retrovirus restriction efficiency.
Bélanger K; Langlois MA
Virology; 2015 Sep; 483():141-8. PubMed ID: 25974865
[TBL] [Abstract][Full Text] [Related]
12. Mapping the Vif-A3G interaction using peptide arrays: a basis for anti-HIV lead peptides.
Reingewertz TH; Britan-Rosich E; Rotem-Bamberger S; Viard M; Jacobs A; Miller A; Lee JY; Hwang J; Blumenthal R; Kotler M; Friedler A
Bioorg Med Chem; 2013 Jun; 21(12):3523-32. PubMed ID: 23545135
[TBL] [Abstract][Full Text] [Related]
13. Crystal structure of DNA cytidine deaminase ABOBEC3G catalytic deamination domain suggests a binding mode of full-length enzyme to single-stranded DNA.
Lu X; Zhang T; Xu Z; Liu S; Zhao B; Lan W; Wang C; Ding J; Cao C
J Biol Chem; 2015 Feb; 290(7):4010-21. PubMed ID: 25542899
[TBL] [Abstract][Full Text] [Related]
14. The HDAC6/APOBEC3G complex regulates HIV-1 infectiveness by inducing Vif autophagic degradation.
Valera MS; de Armas-Rillo L; Barroso-González J; Ziglio S; Batisse J; Dubois N; Marrero-Hernández S; Borel S; García-Expósito L; Biard-Piechaczyk M; Paillart JC; Valenzuela-Fernández A
Retrovirology; 2015 Jun; 12():53. PubMed ID: 26105074
[TBL] [Abstract][Full Text] [Related]
15. APOBEC3F and APOBEC3G inhibit HIV-1 DNA integration by different mechanisms.
Mbisa JL; Bu W; Pathak VK
J Virol; 2010 May; 84(10):5250-9. PubMed ID: 20219927
[TBL] [Abstract][Full Text] [Related]
16. Identification of dominant negative human immunodeficiency virus type 1 Vif mutants that interfere with the functional inactivation of APOBEC3G by virus-encoded Vif.
Walker RC; Khan MA; Kao S; Goila-Gaur R; Miyagi E; Strebel K
J Virol; 2010 May; 84(10):5201-11. PubMed ID: 20219919
[TBL] [Abstract][Full Text] [Related]
17. APOBEC3G rescues cells from the deleterious effects of DNA damage.
Botvinnik A; Shivam P; Smith Y; Sharma G; Olshevsky U; Moshel O; Manevitch Z; Climent N; Oliva H; Britan-Rosich E; Kotler M
FEBS J; 2021 Oct; 288(20):6063-6077. PubMed ID: 33999509
[TBL] [Abstract][Full Text] [Related]
18. A naturally occurring Vif mutant (I107T) attenuates anti-APOBEC3G activity and HIV-1 replication.
Peng J; Ao Z; Matthews C; Wang X; Ramdahin S; Chen X; Li J; Chen L; He J; Ball B; Fowke K; Plummer F; Embree J; Yao X
J Mol Biol; 2013 Aug; 425(16):2840-52. PubMed ID: 23707381
[TBL] [Abstract][Full Text] [Related]
19. Deaminase-independent inhibition of HIV-1 reverse transcription by APOBEC3G.
Iwatani Y; Chan DS; Wang F; Stewart-Maynard K; Sugiura W; Gronenborn AM; Rouzina I; Williams MC; Musier-Forsyth K; Levin JG
Nucleic Acids Res; 2007; 35(21):7096-108. PubMed ID: 17942420
[TBL] [Abstract][Full Text] [Related]
20. HIV-1 subtype variability in Vif derived from molecular clones affects APOBEC3G-mediated host restriction.
Lisovsky I; Schader SM; Sloan RD; Oliveira M; Coutsinos D; Bernard NF; Wainberg MA
Intervirology; 2013; 56(4):258-64. PubMed ID: 23689841
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
